Akebia Therapeutics, Inc. (AKBA) insider trading

By person

30 insiders · 139 transactions

5.4×

John P. Butler holds 5.4 times base salary in stock. $4.68M of shares against $864.01K in salary for 2025.

Salary from the company's own proxy. The shares are what John P. Butler last reported holding, valued at $1.11, the price Common Stock was last bought or sold at on the open market here, on 29 Jun 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Muneer A Satter

Director

$15.00M (1)

—

+$15.00M

3,037,042

1.10%

$3.37M

+51.7%

John P. Butler

CEO and President

$258.59K (2)

$1.54M (21) scheduled

−$1.28M

4,217,314

1.52%

$4.68M

+567.4%

Michel Dahan

SVP, Chief Operating Officer

—

$626.45K (22)

−$626.45K

672,092

0.2425%

$746.02K

+682.8%

Nicole R. Hadas

SVP, Chief Legal Officer

—

$499.66K (21)

−$499.66K

651,243

0.2350%

$722.88K

+530.2%

Steven Keith Burke

SVP, Chief Medical Officer

$96.66K (1)

$460.80K (22)

−$364.14K

948,432

0.3423%

$1.05M

+6,223%

Erik Ostrowski

SVP, CFO, CBO & Treasurer

—

$262.39K (3) scheduled

−$262.39K

616,616

0.2225%

$684.44K

—

Richard C Malabre

SVP, Chief Accounting Officer

—

$239.48K (5) scheduled

−$239.48K

299,390

0.1080%

$332.32K

+6,553%

Nicholas Grund

Chief Commercial Officer

—

$234.72K (3) scheduled

−$234.72K

561,750

0.2027%

$623.54K

—

Adrian Adams

Director

$170.50K (1)

—

+$170.50K

236,200

0.0852%

$262.18K

—

Dell Faulkingham

SVP, CCO

—

$129.09K (6)

−$129.09K

173,841

0.0627%

$192.96K

—

David A Spellman

SVP, CFO and Treasurer

—

$100.72K (7)

−$100.72K

446,483

0.1611%

$495.60K

—

Carolyn M. Rucci

SVP, Chief Legal Officer

—

$96.98K (3) scheduled

−$96.98K

588,378

0.2123%

$653.10K

+25.7%

Duane Nash

Director

—

$81.91K (5)

−$81.91K

21,499

0.0078%

$23.86K

−22.2%

Jason Amello

SVP, CFO & Treasurer

—

$60.69K (1)

−$60.69K

144,642

0.0522%

$160.55K

+240.3%

Maxine Gowen

Director

—

$55.03K (1)

−$55.03K

24,133

0.0087%

$26.79K

+1,756%

Steven C Gilman

Director

$19.89K (1)

$71.99K (3)

−$52.09K

152,830

0.0552%

$169.64K

—

Karen L Tubridy

SVP, Chief Development Officer

—

$30.05K (1)

−$30.05K

84,679

0.0306%

$93.99K

+1,402%

Violetta Cotreau

SVP, Chief Accounting Officer

—

$21.84K (2)

−$21.84K

219,954

0.0794%

$244.15K

+1,605%

Cynthia Smith

Director

$52.80K (1)

$55.26K (1)

−$2.46K

196,633

0.0710%

$218.26K

—

Ellen Snow

SVP, CFO and Treasurer

—

519,300

0.1874%

$576.42K

—

Michael W Rogers

Director

—

197,429

0.0712%

$219.15K

—

Myles Wolf

Director

—

169,081

0.0610%

$187.68K

+1,545%

Ron Frieson

Director

—

165,200

0.0596%

$183.37K

—

Leanne M Zumwalt

Director

—

145,100

0.0524%

$161.06K

—

Rita Jain

SVP, Chief Medical Officer

—

96,332

0.0348%

$106.93K

—

Bradley Maroni

SVP and Chief Medical Officer

—

64,585

0.0233%

$71.69K

+57.2%

Jodie Pope Morrison

Director

—

58,619

0.0212%

$65.07K

—

Michael Thomas Heffernan

Director

—

48,586

0.0175%

$53.93K

—

Mark J Enyedy

Director

—

31,143

0.0112%

$34.57K

—

Scott A Canute

Director

—

13,700

0.0049%

$15.21K

—

Akebia Therapeutics, Inc.

What the insiders did Net buying

By person